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Abstract
Haematology/oncology children are usually at risk for various infections after intensive chemotherapy. We evaluated the quantiﬁcation
of Th1/Th2 cytokines with a ﬂow cytometric bead array (CBA) in 795 hospitalized haematology/oncology children (309 febrile and 486
afebrile patients) to seek for a diagnostic method for determination of the type and the severity of infection. Three hundred and nine
febrile patients developed a total of 505 febrile episodes. Microbiological examination demonstrated a positive blood culture (microbio-
logically documented infection (MDI)) in 145/505 febrile episodes. The controls included 550 healthy children, 43 haemophagocytic
lymphohistiocytosis (HLH) patients, 35 cytomegalovirus infection patients and 19 Epstein–Barr virus infection patients. Interleukin (IL)-4,
IL-6, IL-10, tumour necrosis factor (TNF)-a and interferon (IFN)-c levels in febrile episodes were signiﬁcantly higher than those in
healthy children, and the cytokine proﬁle was different from that of the HLH controls or the viral infection controls. IL-6 levels were
much higher in MDI patients (usually >1000.0 pg/mL, 60/145) than in HLH patients (2/43); however, IFN-c levels were only slightly
increased in MDI patients, rarely being more than 100.0 pg/mL (8/145 vs. 39/43 in HLH patients). The median levels of IL-4, IL-6, IL-10,
TNF-a and IFN-c in febrile patients before antibiotic therapy were 3.9, 660.1, 122.7, 6.9 and 11.4 pg/mL, respectively, and returned to 3.3,
22.8, 9.6, 4.1 and 6.4 pg/mL, respectively, after infection was controlled. IL-6 and IL-10 levels were positively associated with septic
shock and mortality rates. In conclusion, our results have demonstrated the usefulness of IL-6/IL-10/TNF-a/IFN-c determination with CBA
technology for the early rapid diagnosis, severity evaluation and assessment of therapy effect in febrile haematology/oncology children.
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Introduction
Treatment of leukaemia and other malignant tumours by
chemotherapy suppresses the immune system and increases
susceptibility to infection. In most cases, fever is an early and
important sign of infection, but clinical signs are non-speciﬁc,
and fever can be attributed to other causes. Furthermore,
the presently available laboratory techniques such as C-reac-
tive protein (CRP) and procalcitonin [1] determination, do
not have high sensitivity or speciﬁcity for early diagnosis of
infection in these patients. Although bacterial culture with
sensitivity testing using a variety of specimens, such as blood,
sputum, secretions, and body ﬂuids, is the most important
method for guiding antibiotic selection, the positive rate is
low, especially in patients with haematology/oncology malig-
nancies, who have usually been heavily treated with antibiot-
ics [2]. Thus, the current management of febrile episodes in
immunocompromised children is primarily based on empirical
broad-spectrum antibiotics. However, widespread use of
broad-spectrum antibiotics may be associated with the emer-
gence of resistant strains and increases in treatment costs.
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ORIGINAL ARTICLE INFECTIOUS DISEASES
Recently, attention has been paid to the role of cytokines
in the diagnosis of infection. Most studies have focused on
interleukin (IL)-6 [3–6], IL-8 [7,8], or both [9,10], and mea-
surement of these cytokines by ELISA. A ﬂow cytometric
bead array (CBA)-based immunoassay has been developed to
measure six Th1/Th2 cytokines (IL-2, IL-4, IL-6, IL-10,
tumour necrosis factor (TNF)-a, and interferon (IFN)-c)
simultaneously and quickly in a small volume of serum
[11–13]. CBA technology has a comparable analytical sensi-
tivity to that of ELISA, with a correlation coefﬁcient of >90%
[14,15]. Furthermore, the CBA technique has a wider detec-
tion range, is less labour-intensive, and requires a smaller
sample volume, approximately one-sixth of the quantity nec-
essary for conventional ELISA assays [16]. More importantly,
the results can be available within a few hours after the
blood sample has been taken. Our recent study showed that
Gram-positive and Gram-negative bacteria had different cyto-
kine patterns in 145 cases with positive blood cultures, and
this allowed us to establish the bacterial infection-related
cytokine patterns for Gram-positive and Gram-negative
bacteraemia. These bacterial infection-related cytokine pat-
terns can be successfully used for infected patients with a
negative culture result, to quickly judge the possible type of
bacterium and to adjust the antibiotics appropriately and
immediately [17].
In this study, we further investigated the potential role of
Th1/Th2 cytokines evaluated by CBA technology as indica-




Neutropenia was deﬁned as an absolute neutrophil count in
peripheral blood of <0.5 · 109/L [18]. Febrile episodes were
deﬁned as one axillary temperature measurement ‡38.5C
or two measurements of 38–38.4C made within a 4-h inter-
val [18]. When a causative pathogen was isolated from blood
or any body ﬂuid/swab, microbiologically documented infec-
tion (MDI) was deﬁned [8]. All of the MDI patients, those
with febrile episodes lasting >7 days and febrile patients who
suffered from septic shock or death were considered to
have severe infection. Septic shock was deﬁned as a systolic
blood pressure of <90 mmHg or organ dysfunction attribut-
able to sepsis [19].
Patients and controls
From August 2005 to July 2009, 795 newly admitted children
(537 boys and 258 girls, with a median age of 6.4 years
(range, 3 months to 18 years)) with acute leukaemia, aplastic
anaemia, immune thrombocytopenic purpura, neuroblastoma
and lymphoma treated in our hospital were enrolled in the
study. A total of 1355 samples were collected for determina-
tion of IL-2, IL-4, IL-6, IL-10, TNF-a, and IFN-c. Three hun-
dred and nine febrile children (182 boys and 127 girls, with a
median age of 6.8 years (range 3 months to 17.5 years))
developed a total of 505 febrile episodes. Children with feb-
rile neutropenia were allocated to a febrile neutropenia sub-
group. The remaining 486 afebrile children were allocated to
the new admission group. The healthy control samples were
taken from 550 normal children (306 boys and 244 girls,
with a median age of 6.5 years (range, 6 months to
14.5 years)) at the time of routine physical checkup without
any evidence of infection. Because hypercytokinaemia is
also seen in patients with haemophagocytic lymphohistiocy-
tosis (HLH), 43 HLH children were enrolled as an HLH
control group. We also chose another 35 non-haematolo-
gy/oncology patients with deﬁnitive cytomegalovirus (CMV)
infection and 19 with deﬁnitive Epstein–Barr virus (EBV)
infection as a viral infection control group. This study was
approved by the Ethics Review Board of the Children’s
Hospital, Zhejiang University School of Medicine, and
informed consent was obtained from the parents or guard-
ians of the patients.
Cytokine assay
The serum cytokines of all patients were examined at the
time of admission, during febrile episodes and during conva-
lescent periods when the temperature returned to normal
for at least 24 h. The routine blood test, CRP determination
and blood culture were performed at the same time. The
concentrations of IL-2, IL-4, IL-6, IL-10, TNF-a and IFN-c in
the sera were quantitatively determined immediately after
clotting (the sera were usually available 1 h after blood sam-
pling) with the CBA Human Th1/Th2 Cytokine kit II (BD
Biosciences, San Jose, CA, USA), as previously described in
the literature [20]. A standard calibration curve was estab-
lished for each kit. The maximum and minimum limits of
detection for all six cytokines were 1.0 and 5000 pg/mL,
respectively. The investigators performed the assays while
blinded to the clinical status of the patients. If the results
were very unusual, with the levels of all six cytokines being
signiﬁcantly elevated, the samples were retested. The results
were available to clinicians within 5 h after sample collection.
Statistical analysis
All statistical analyses were performed with SPSS software,
version 12.0. The Wilcoxon rank sum test was used to
compare the groups at the time of infection and after the
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infection was controlled. Serum concentrations of cytokines
were compared between the groups with febrile episodes,
the healthy controls and the newly admitted haematology/
oncology children without fever by use of the Mann–Whitney
U-test for comparison of results between two groups or the
Kruskal–Wallis H-test for comparison of data between more
than two groups. A two-sided p-value of <0.05 was consid-
ered to be statistically signiﬁcant.
Results
Patient characteristics
The diagnoses of the 795 patients included 414 cases of
acute lymphoblastic leukaemia, 166 cases of acute myeloid
leukaemia, 93 cases of aplastic anaemia, 84 cases of immune
thrombocytopenic purpura, 27 cases of neuroblastoma, and
11 cases of lymphoma. Among the 505 febrile episodes,
there were 309 (61.2%) episodes with neutropenia. Microbio-
logical examination demonstrated a positive blood culture
(MDI) in 145/505 (28.7%) of the febrile episodes; of these, 54/
145 (37.2%), 88/145 (60.7% and 3/145 (2.1%) were Gram-
positive bacteria, Gram-negative bacteria and fungi, respec-
tively. During the data analysis, we found that there were no
signiﬁcant differences between the cytokine proﬁles for the
different malignancies, so all 486 afebrile children were consid-
ered to be the new admission group.
Th1/Th2 cytokines in febrile episodes
IL-4, IL-6, IL-10, TNF-a and IFN-c levels of febrile episodes
were all signiﬁcantly higher than those in healthy controls
(p <0.001; Table 1). All of the Th1/Th2 cytokine levels deter-
mined, except for IL-2 in the MDI patients, were statistically
higher than those in the healthy control group and the new
admission group (p <0.001; Fig. 1). In HLH patients, IFN-c
and IL-10 levels were signiﬁcantly elevated and IL-6 levels
were moderately elevated, but in MDI patients, IL-6 levels
were much higher (usually >1000.0 pg/mL) than in HLH
patients (60/145 (41.4%) vs. 2/43 (4.7%); p <0.001); however,
IFN-c levels were only slightly increased in MDI patients,
being rarely more than 100.0 pg/mL (8/145 (5.5%) vs. 39/43
(90.7%) in HLH patients; p <0.001). IL-10 levels were highly
elevated in patients with both diseases, but the rate in HLH
cases (21/43 (48.8%) with high levels of IL-10 (>1000.0 pg/
mL)) was signiﬁcantly higher than that (17/145 cases (11.7%);
p <0.05) in MDI patients. Among the viral infection controls
(EBV and CMV), the IL-6 and IL-10 levels in the CMV group
and the IL-6 levels in the EBV group were all signiﬁcantly
lower than those in the febrile episode group (p <0.001).
The IFN-c levels in the EBV and CMV infection groups were
slightly higher than those in the febrile episodes group,
but no signiﬁcant differences were identiﬁed statistically
(p >0.05). Among the febrile group, the neutropenia sub-
group and the non-neutropenia subgroup had comparable
cytokine levels (p >0.05), indicating that the absolute
neutrophil count did not affect the cytokine levels.
Septic shock and mortality
Among 505 febrile episodes, 25 episodes in 25 patients
(5.0%) involved from septic shock; 22 (91.7%) of these
patients were neutropenic. The IL-2, IL-4, IL-6, IL-10, TNF-a
and IFN-c levels were 3.2 (2.3–150.1), 4.7 (2.3–54.9), 2430.6
(155.0–>5000), 418.9 (27.8–>5000), 6.5 (3.3–2140.7) and
10.5 (2.7–394.9) pg/mL, respectively; these levels were signif-
icantly higher than those (3.0 (1.0–13.5), 3.5 (1.0–39.3), 98.4
(3.8–>5000), 20.4 (3.4–>5000), 4.5 (1.7–4263.4) and 10.1
(1.8–834.1) pg/mL, respectively) (p <0.001; Fig. 2) in the
remaining 480 febrile episodes (284 patients) without septic
shock. In the non-septic shock group, 287/480 (59.8%) cases
were neutropenic.
The IL-6 levels exceeded the maximum detection limits
(>5000 pg/mL) in 13 MDI patients, six of whom (46.2%)
TABLE 1. Th1/Th2 cytokine levels in different groups
Groups N IFN-c (pg/mL) TNF-a (pg/mL) IL-10 (pg/mL) IL-6 (pg/mL) IL-4 (pg/mL) IL-2 (pg/mL)
Febrile 505a 10.1 (1.8–834.1) 4.6 (1.7–4263.4) 21.4 (3.4–>5000) 107.0 (3.8–>5000) 3.5 (1.0–54.9) 3.0 (1.0–150.1)
Positive 145a 10.4 (2.7–203.2) 5.2*** (2.5–4263.4) 56.0*** (3.4–>5000) 327.2*** (8.5–>5000) 3.6 (1.4–39.3) 3.1 (1.3–11.6)
Negative 360a 10.0 (1.8–834.1) 4.3 (1.7–888.2) 17.6 (3.9–>5000) 71.5 (3.8–>5000) 3.4 (1.0–54.9) 3.0 (1.0–150.1)
New admission 486a 5.4** (1.0–80.3) 4.6 (1.7–65.6) 10.4** (3.6–72.3) 9.4** (3.0–77.8) 3.2** (1.0–17.4) 2.7 (1.0–14.4)
HLH control 43b 787.5** (9.6–>5000) 4.7 (1.0–>5000) 483.0** (10.4–>5000) 47.7* (6.6–>5000) 4.4** (1.6–62.5) 2.7 (1.0–19.3)
CMV control 35b 12.2 (2.8–83.5) 4.6 (1.7–84.7) 15.4** (5.6–52.9) 16.1** (3.8–226.7) 3.4 (1.9–5.8) 2.9 (1.6–6.1)
EBV control 19b 22.2 (3.5–123.7) 4.0* (2.2–13.0) 34.4 (10.2–190.7) 22.2** (9.9–70.2) 3.1 (1.3–6.1) 2.3 (1.6–6.6)
Healthy control 550b 5.6** (1.2–18.7) 4.1** (1.3–9.9) 6.6** (1.9–27.4) 6.1** (1.3–40.6) 3.2** (1.0–9.2) 3.0 (1.1–6.4)
CMV, cytomegalovirus; EBV, Epstein–Barr virus; HLH, haemophagocytic lymphohistiocytosis; IFN, interferon; IL, interleukin; TNF, tumour necrosis factor.
Data were given as median (range). Febrile, febrile episodes caused by infection; Positive, blood culture-positive; Negative, blood culture-negative; New admission, newly
admitted patients with acute leukaemia, aplastic anaemia, immune thrombocytopenic purpura, lymphoma and neuroblastoma without fever. ***p <0.001 (as compared with
the blood culture-negative group); **p <0.001, *p <0.01 (as compared with the febrile group).
aThe number represents episodes.
bThe number represents cases.
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suffered from septic shock, with four deaths resulting
(30.8%). The IL-10 levels exceeded 1000.0 pg/mL in 17 MDI
patients, six of whom (35.3%) suffered from septic shock,
with three deaths resulting (17.7%). The IL-6 and IL-10 levels
were positively associated with septic shock and mortality
rates.
Response to antibiotic therapy
Antibiotics were given in all the febrile episodes. We com-
pared the cytokine levels during initial infection before antibi-
otic therapy (fever within 24 h) with those after the
infection had been controlled in 60 cases, 49 of whom were
neutropenic; these were selected on the basis of the fact
that the cytokine levels at the time of febrile onset and when
the temperature returned to normal were both available.
The IL-4, IL-6, IL-10, TNF-a and IFN-c levels of the patients
at the time of febrile onset before antibiotic therapy were
3.9 (1.4–54.9), 660.1 (16.0–>5000), 122.7 (7.0–>5000), 6.9
(2.7–4263.4) and 11.4 (3.1–473.9) pg/mL, respectively, and
were signiﬁcantly decreased after infection had been con-
trolled (3.3 (1.3–5.6), 22.8 (3.9–363.0), 9.6 (4.6–54.7), 4.1
(2.0–11.1) and 6.4 (2.0–135.1) pg/mL, respectively)
(p <0.001; Fig. 3b,f). The IL-2 levels were comparable
(p >0.05; Fig. 3a) in these two groups. The interval between
the two detections was 5.5 (2–24) days.
Receiver operating characteristic curve
The receiver operating characteristic curve analysis showed
that the IL-6, IL-10 and TNF-a levels were useful in differenti-
ating patients with bacteraemia, discriminating between
Gram-positive and Gram-negative infections, and determining
the severity of infections (Table 2). When the cut-off values of
IL-6, IL-10 and TNF-a were set at 227.7, 42.0 and 4.6 pg/mL,
respectively, the sensitivity and speciﬁcity of severe infection
FIG. 1. Comparison of cytokine levels among patients with microbiologically documented infection (MDI), healthy controls and newly admitted
patients with acute leukaemia, aplastic anaemia, immune thrombocytopenic purpura, neuroblastoma, and lymphoma without fever (new admission
group). (a) Interleukin (IL)-2; (b) IL-4; (c) IL-6; (d) IL-10; (e) tumour necrosis factor (TNF)-a; (f) interferon (IFN)-c.
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prediction were 70.0% and 85.0%, 62.0% and 85.0%, and 60.0%
and 60.0%, respectively. When the IL-6 cut-off value was set at
227.7 pg/mL, the sensitivity and speciﬁcity of Gram-negative
bacteraemia prediction were 75.0%, and 60.0%, respectively,
and with CRP at a cut-off value of 17.5 mg/L. the sensitivity
and speciﬁcity were 88.6% and 20.0%, respectively. When the
cut-off values of IL-6 and CRP were set at 40.6 pg/mL and
8.0 mg/L, respectively, the sensitivity and speciﬁcity of Gram-
negative bacteraemia prediction were 92.0% and 27.7%, and
97.0% and 11.1%, respectively. Our data suggest that IL-6
could be a more valuable biomarker than CRP in hospitalized,
febrile haematology/oncology children.
Discussion
Although cytokines induced by various infections and their clin-
ical relevance have been investigated by several groups, their
application in clinical practice has not been generally accepted.
One reasons for this is that, in most studies, a single cytokine is
studied, and the impact of the cytokine patterns on the diagno-
sis and prediction of infections is neglected. The second reason
is that the cytokine result is usually late, owing to the method
used (usually ELISA), and thus offers limited help to clinicians in
selection of the correct antibiotics. Third, the case number
reported is usually small, with limited types of infection. In this
study, we measured the cytokine levels in a large series of
patients with various types of infection and hypercytokinaemia,
including viral infection and HLH, which allowed us to assess
the clinical signiﬁcance for each patient subgroup.
Karan [3] and Kitanovshi et al. [6] found that IL-6 levels
were able to guide the management of febrile neutropenic
patients, and could be used as predictive factors for poor
outcome. In their studies, IL-6 was a more sensitive and spe-
ciﬁc early marker for bacteraemia/clinical sepsis than CRP in
children with febrile neutropenia. Persson et al. [5] con-
cluded that low plasma concentrations of IL-6 during the ﬁrst
8 days of fever could be a good predictor of no subsequent
complications in neutropenic patients, and could therefore
be helpful as a tool for limiting antimicrobial therapy. How-
ever, Lehrnbecher et al. [21] found that IL-6 and IL-8 levels
had limited diagnostic value as early markers of severe infec-
tion in febrile neutropenic children.
Our study has shown that, in febrile children, elevated levels
of Th1/Th2 cytokines, including IL-4, IL-6, IL-10, TNF-a, and
IFN-c, particularly IL-6 and IL-10, indicate bacterial infection.
These cytokine changes are partially consistent with those in
previous reports [3,18]. Hypercytokinaemia is also seen in var-
ious diseases, such as HLH [20,22,23], macrophage activation
syndrome [24–26], and severe inﬂammatory response
syndrome [27–29]. However, our previous report on HLH
patients and this study have shown that the sepsis caused by
Gram-negative bacteria and HLH have totally different
cytokine patterns [20]. The different cytokine patterns make it
easier to distinguish between these two kinds of hypercytoki-
naemia. Our cohort also showed that, as the levels of IL-6 and
IL-10 increased, the rates of both septic shock and mortality
increased, indicating that the levels of IL-6 and IL-10 might be
good predictors of infection severity and prognosis.
The IL-6, IL-10 and TNF-a levels showed predictive value
in sepsis and determination of the severity of infection. Cut-
off values of 40.6 pg/mL for IL-6, 20.0 pg/mL for IL-10 and
4.2 pg/mL for TNF-a might be important parameters for dis-
tinguishing patients with a high probability of having a bacte-
rial infection from those with a low probability. To judge a
severe infection, the cut-off values of IL-6, IL-10 and TNF-a
can be set at 227.7, 42.0 and 4.6 pg/mL, respectively.
In summary, our results have added extra information to
that obtained in our previous study [17,20], and have shown
the promise of IL-6/IL-10/TNF-a/IFN-c determination with
CBA technology for the early and rapid diagnosis, evaluation
of severity and assessment of the therapy effect of infections
in hospitalized, febrile haematology/oncology children, even
in the situations where there are negative blood culture
results. Whether cytokine level measurements can be as an
FIG. 2. Comparison of the cytokine levels between febrile patients
with or without septic shock. (a) Interleukin (IL-4); (b) IL6; (c) IL-10;
(d) tumour necrosis factor (TNF)-a.
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FIG. 3. Comparison of Th1/Th2 cytokine levels at onset of infection and after the infection had been controlled. The former sample was taken
at the time of fever within 24 h, and the latter was taken when the body temperature had returned to normal for at least 24 h. All of the
elevated cytokine levels signiﬁcantly decreased after infection had been controlled, except for interleukin (IL)-2 (p <0.001). (a) IL-2; (b) IL-4;
(c) IL-6; (d) IL-10; (e) tumour necrosis factor (TNF)-a; (f) interferon (IFN)-c.






Prediction of severe infection
(%)
Sensitivity Speciﬁcity Sensitivity Speciﬁcity Sensitivity Speciﬁcity
IL-6 (pg/mL) 22.7 96.0 36.5 97.0 12.1 98.0 25.0
40.6 90.0 72.0 92.0 27.7 90.0 46.6
227.7 55.5 100.0 75.0 60.0 70.0 85.0
IL-10 (pg/mL) 8.2 90.0 19.2 98.0 18.3 95.0 17.1
20.0 65.0 62.9 82.0 49.0 75.0 61.6
42.0 46.0 87.0 70.0 67.0 62.0 85.0
TNF-a (pg/mL) 3.3 85.0 17.0 90.0 10.0 90.0 20.0
4.2 60.0 44.7 75.0 43.0 71.1 54.1
4.6 51.0 56.0 74.0 56.0 60.0 60.0
CRP (mg/L) 8.0 92.0 33.0 97.0 11.1 90.6 21.6
17.5 83.3 51.0 88.6 20.0 80.0 34.2
157.5 24.6 97.0 25.7 78.0 27.2 90.0
CRP, C-reactive protein.
aPrediction of Gram-negative bacteraemia: discriminating the Gram-positive and Gram-negative organisms.
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indicator to guide the earlier discontinuation of antibiotic
use is now under investigation.
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